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Dengue virus type 2 was isolated from a tourist who returned 
from Borneo to Australia. Phylogenetic analysis identified 
this virus as highly divergent and occupying a basal phy-
logenetic position relative to all known human and sylvatic 
dengue virus type 2 strains and the most divergent lineage 
not assigned to a new serotype.
Outbreaks of dengue have been reported for several centuries in the Old World and the New World. Den-
gue is a major cause of illness and death globally, and there 
are high levels of infection in many tropical and subtropi-
cal localities populated by Aedes mosquito vectors. Despite 
their role in public health, the origin of the 4 serotypes of 
dengue virus (DENV-1–DENV-4) that are the causative 
agents of what now is defined as dengue remains unclear.
In 1967, Rudnick et al. (1) combined a fragmentary 
body of evidence to propose that dengue might have a 
sylvatic (jungle) cycle similar to that of another flavivirus 
(yellow fever virus). Isolation of 4 serotypes of DENV 
from humans in the Asia–Pacific region during 1943–1956 
(2–4) was compatible with the idea that DENV might have 
originated in this region. Genome sequences of DENV-2 
and DENV-4 isolated from sylvatic settings (i.e., from non-
human primates) occupied basal positions on phylogenetic 
trees of those serotypes, which suggested that each DENV 
serotype evolved separately in sylvatic settings before lat-
er, independent, cross-species transmission to humans in 
urban and semiurban settings (5,6).
DENV-2 and DENV-4 have been isolated from nonhu-
man primates and occupy divergent phylogenetic positions, 
which suggests that that they are truly sylvatic. In contrast, 
no sylvatic strains have been identified as DENV-3, and an 
early sylvatic strain of DENV-1 probably was a spillback 
from humans to other primates (6). However, a highly di-
vergent sequence of DENV-1, which was isolated from a 
patient who had vacationed in Brunei, was recently reported 
(7). This virus was basal to all other strains of DENV-1 by 
phylogenetic analyses, which suggests the presence of an-
other sylvatic virus lineage in Southeast Asia, albeit of un-
known animal origin.
Despite the central role of sylvatic viruses in our un-
derstanding of evolution and emergence of human dengue 
(6), to our knowledge, there are no reports of continuous 
transmission of sylvatic strains of DENV in a truly sylvatic 
setting. Much of the uncertainty over the nature and role 
of sylvatic DENV arises because of the small number of 
such isolates available and the lack of studies of DENV 
ecology outside a human setting. Thus, although phyloge-
netic divergence alone is insufficient to definitively prove 
the existence of sylvatic transmission, it at least shows that 
a greater diversity of viruses exist than are usually assigned 
as causing dengue in humans. In this report, we describe a 
highly divergent strain of DENV-2 isolated from an acute-
phase serum specimen from a patient (human ethical ap-
proval for this study precludes identification of the patient) 
in whom dengue developed after the patient returned from 
a vacation in Borneo to Australia in early 2015.
The Study
The study was approved by the Queensland University of 
Technology (Brisbane, Queensland, Australia) (Human 
Research Ethics approval no. 1300000333). DENV-2 was 
isolated from a serum specimen by cultivation in Aedes al-
bopictus mosquito C6-36 cells.
The virus was recognized by pan-flavivirus mono-
clonal antibodies 6B-6C1 (8) and 4G2 (9) and DENV-2–
specific monoclonal antibodies 3H5 (9), 5H12, and 6B2 
(10) in indirect immunofluorescence assays with infected 
C6-36 cells. However, it was not recognized by monoclo-
nal antibody 6F3.1, which reacts with a serologic epitope 
9RNTPFNMLKRE19 in the capsid protein of nonsylvatic 
strains of DENV-2.
The consensus sequence of the viral genome was ob-
tained by using 3′ and 5′ random amplification of cDNA 
ends (11,12) and reverse transcription PCR of ≈1-kb 
overlapping regions of the genome. Sequences of puri-
fied cDNA fragments generated by reverse transcription 
PCR were determined by using the dye di-deoxy chain 
termination method at the Australian Genome Research 
Facility (Brisbane).
Phylogenetic analysis of the complete viral genome 
(10,736 nt) by using maximum-likelihood methods (13) un-
ambiguously placed this sequence, denoted QML22/2015 
(GenBank accession no. KX274130), as a highly divergent 
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member of DENV-2 with a strikingly basal phylogenetic 
position relative to all human and sylvatic DENV-2 se-
quences isolated (Figure 1). This lineage is the most di-
vergent new lineage of DENV identified, even greater than 
that of DENV-1 Brun2014 (7), and is located approximate-
ly midway between the genetic divergence seen at the level 
of serotypes and that of genotypes within serotypes.
Although the nucleotide sequence of the open read-
ing frame of QML22/2015 was strikingly different from 
those of other strains of DENV-2, sequence and predicted 
secondary RNA structure of 5′ and 3′ untranslated regions 
of the QML22/2015 genome were nearly identical with 
those of other strains of DENV-2, which confirmed the 
critical role of these elements in virus replication. Slid-
ing-window analysis of genetic distance across the viral 
genome showed no regions in which QML22/2015 was 
disproportionately similar to human DENV-2 sequences 
(Figure 2).
Conclusions
Although it is tempting to estimate the time of origin of this 
novel DENV-2, as performed for other divergent DENV 
 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 22, No. 12, December 2016 2147
Figure 1. A) Maximum-likelihood phylogenetic tree of 500 complete genome sequences of DENV-1–DENV-4 (alignment length of 10,185 
nt), including QML22/2015, estimated by using the generalized time-reversible invariable sites gamma model of nucleotide substitution 
in PhyML (13) and nearest-neighbor interchange plus subtree pruning and regrafting branch-swapping. The tree is midpoint rooted 
for clarity, and sequences are color coded according to their putative transmission cycle (human, black; sylvatic, blue); red indicates 
the highly divergent QML22/2015 lineage isolated in this study. B) Regression of root-to-tip genetic distances of 119 representative 
human and sylvatic complete genome sequences of DENV-2 (alignment length 10,173 nt) against time (year) of sampling. The input 
phylogenetic tree was estimated by using the same maximum-likelihood procedure. Three regression lines and slopes are shown; 
slopes indicate an estimate of the virus nucleotide substitution rate (substitutions/site/year). Blue line indicates rate for entire DENV-2 
data set; dashed line indicates rate for sylvatic DENV-2 sequences; black line indicates rate for human DENV-2 sequences. There is a 
marked difference between sylvatic and human rates. DENV, dengue virus.
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lineages (7), we have not made this estimation because our 
data provided strong evidence for a marked difference in 
evolutionary rate between human and sylvatic strains of 
DENV-2, which will confound all attempts at molecular 
clock dating. Regression analysis of root-to-tip genetic dis-
tances against time (year) of sampling suggests that sylvat-
ic strains of DENV-2 are evolving slower than urban (hu-
man) strains, most likely because of differences in selection 
pressure, replication dynamics, or both, and in contrast to 
previous observations (15).
The QML22/2015 isolate is closer to the human dis-
tribution than the sylvatic distribution of root-to-tip genetic 
distances, which suggests that this lineage might not have 
had only sylvatic transmission during its evolutionary his-
tory. Further studies are needed to determine whether this 
virus has infected other humans in Indonesia or other locali-
ties and identify genotypic changes that might give this virus 
distinctive phenotypic properties. The discovery of this and 
other highly divergent strains of DENV further emphasizes 
the need for biodiversity surveys of this major group of vi-
ruses in animals other than humans. It also suggests that gaps 
in DENV phylogeny might be filled after wider sampling.
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Figure 2. Sliding-window analysis of mean genetic (nucleotide) 
distance across the dengue virus type 2 (DENV-2) genome. Red 
line indicates comparison between QML22/2015 and human DENV-
2 sequences. Equivalent analyses were performed on sylvatic 
DENV-2 versus human DENV-2 (blue line) and within the human 
DENV-2 sequences (black line). This analysis was based on genetic 
distances calculated by using sliding windows of 200 nt on the 
DENV-2 data described in Figure 1 and was performed by using the 
Analysis of Phylogenetics and Evolution Package in R software (14).
